Pulmonary Arterial Hypertension (PAH)

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

“In this video we discuss the pathophysiology of pulmonary arterial hypertension, along with how the soluble Guanylate Cyclase activator Riociguat is useful in treating it.” Watch the videos below to see the full explanation, as well as part 2, 3 and 4 of this series of 4 videos.

 

Learn more about pulmonary arterial hypertension here: https://bit.ly/1P75Bxf

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

pulmonary arterial hypertension (PAH), Pulmonary hypertension (PHT)

Recent Posts


Recommended reading